Course administration of ultralow doses of antibodies to S-100 protein restores cognitive functions and neurological status, improves emotional state, and reduces anxiety in animals with modeled Alzheimer disease based on cholinergic system defi ciency caused by subchronic treatment with scopolamine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
T. A. Voronina and R. U. Ostrovskaya, Manual on Experimental (Preclinical) Study of New harmacological Substances. Ed. R. U. Khabriev [in Russian], Moscow (2005), pp. 308-320.
I. V. Gannushkina, Zh. Nevrol. Psikhiatr., No. 1, 14-18 (1996).
X. Barril, S. G. Kalko, M. Orozco, and F. J. Luque, Mini Rev. Med. Chem., 2, No. 1, 27-36 (2002).
P. Camps and D. Munos-Torrero, Ibid., pp. 11-25.
J. J. Claus, C. Ludwig, E. Mohr, et al., Neurology, 41, No. 4, 570-574 (1991).
A. H. Gouliaev and A. Senning, Brain Res. Brain Res. Rev., 19, No. 2, 180-222 (1994).
S. Рellow and S. E. File, Pharmacol. Biochem. Behav., 24, No. 3, 525-529 (1986).
M. Pomponi, E. Giacobini, and M. Brufani, Aging. (Milano)., 2, No. 2, 125-153 (1990).
T. A.Voronina, Alzheimer Disease: Therapeutic Strategies. Eds. E.Giacobini et al. Boston (1994).
Author information
Authors and Affiliations
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 148, Suppl. 1, pp. 174-176, September, 2009
Rights and permissions
About this article
Cite this article
Voronina, T.A., Belopol’skaya, M.V., Kheyfets, I.A. et al. Effect of Ultralow Doses of Antibodies to S-100 Protein in Animals with Impaired Cognitive Function and Disturbed Emotional and Neurological Status under Conditions of Experimental Alzheimer Disease. Bull Exp Biol Med 148, 533–535 (2009). https://doi.org/10.1007/s10517-010-0757-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-010-0757-y